CLICK HERE TO REGISTER
Teleconference Series with Live Q&A Sessions
Advances in the Management of
Attention-Deficit/Hyperactivity Disorder:
An Evidence-Based Update for Managed Care

Jointly sponsored by the University of Cincinnati and Princeton CME
Participating Faculty
Presenters/Q&A Cohosts
Jeffrey H. Newcorn, MD
Associate Professor
Psychiatry and Pediatrics
Director
Child and Adolescent Psychiatry
Mount Sinai School of Medicine
New York City, New York
Julie A. Dopheide, PharmD, BCPP
Associate Professor of Clinical Pharmacy,
Psychiatry, and the Behavioral Sciences
University of Southern California
Schools of Pharmacy and Medicine
Los Angeles, California
Independent Clinical Reviewer
Steven W. Evans, PhD
Alvin V. Baird Jr. Centennial Chair of Psychology
Director, Alvin V. Baird Attention & Learning Disabilities Center
James Madison University
Harrisonburg, Virginia
Target Audience
This activity is designed for managed markets physicians and pharmacists.
Learning Objectives
After completing this activity, participants should be able to:

• Summarize the prevalence and clinical and economic burden of ADHD in children and adults
• Describe the importance of consistent ADHD management to improve outcomes and avoid comorbidities
• Outline current data regarding the benefits and limitations of traditional, new, and emerging pharmacotherapies for ADHD management
• Apply the evidence to assist in implementation of effective strategies for the screening, diagnosis, and management of ADHD

Activity Overview
The teleconference lecture will be presented on 4 dates in May by Jeffrey H. Newcorn, MD, and Julie A. Dopheide, PharmD, BCPP, with a live question-and-answer session following each presentation.

• Monday, May 21, 2-3 pm ET
• Wednesday, May 23, 1-2 pm ET
• Thursday, May 24, 3-4 pm ET
• Thursday, May 31, Noon-1 pm ET

To participate, dial toll-free 800-803-7101 approximately 5 minutes before the scheduled time of the teleconference. Upon calling in, provide the activity code, ADHD.
An activity booklet, including the lecture slides, post-test, and evaluation form, will be forwarded to each participant prior to the start of the teleconference series. To be eligible for documentation of credit, all participants must attend a full teleconference event, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit. Those who mail or fax back their successfully completed post-test and evaluation form will receive documentation of credit by mail within 6 weeks.
There is no fee associated with this activity.
CME Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Cincinnati and Princeton CME. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CPE Accreditation
 Princeton CME is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education (ACPE Provider #452) and complies with the Criteria for Quality and Interpretive Guidelines. This activity is approved for 1 hour credit (0.1 CEU) of continuing pharmacy education (ACPE #452-999-07-012-L01).
Grant Support
This activity is supported by an educational grant from Shire Pharmaceuticals, Inc.
Representatives of the granting organization may not register on behalf of participants.  
CLICK HERE TO REGISTER